Balyasny Asset Management’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $2.26M | Buy |
|
|||||
|
2025
Q1 | $1.47M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $103K | Sell |
|
|||||
|
2024
Q1 | $423K | Buy |
|
|||||
|
2023
Q4 | $645K | Buy |
|
|||||
|
2023
Q3 | $166K | Sell |
|
|||||
|
2023
Q2 | $359K | Buy |
|
|||||
|
2023
Q1 | $259K | Sell |
|
|||||
|
2022
Q4 | $546K | Buy |
|
|||||
|
2022
Q3 | $589K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $61K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $98K | Buy |
|